Upgrade

Mereo BioPharma Group plc

MREO

Last
$0.35
Day
-6.7%
1y
-82.1%
5y
-83.9%
52w
-84.2%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0930d
EMA 21
0.34
EMA 50
0.32
EMA 200
0.59
20d high
-11.3%
5y high
-92.5%
5y range
4th
Website · 39 employees · United Kingdom

Positions held

Your positions

MREO isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
55
Hold
swing
Signal
Strong Buy
Target
$0.44
Stop
$0.32
Stop distance
8.6%
Target vs last
+25.8%

Fundamentals

Market cap$59.92MEnterprise value$30.83MTrailing P/E—Forward P/E-16.39
PEG—Price / book2.08Beta0.14Dividend yield0.00%
Revenue growth—Earnings growth—Gross margin0.0%Operating margin0.0%
Profit margin0.0%ROE-67.8%ROA-42.5%Debt / equity0.04
Current ratio5.88Free cash flow-$13.66MAnalyst recommendationnoneMean target$1.96
52w high$2.3752w low$0.20

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q22025-Q1
Revenue$0.0M$0.0M$0.0M$0.0M$0.5M—
Op margin————-1950.8%—
Net income-$7.0M-$6.7M-$7.4M-$7.0M-$14.6M—
Gross margin————73.6%—
Gross profit$0.0M—$0.0M$0.0M$0.4M—
Operating income-$6.9M-$8.7M-$7.9M-$9.6M-$9.8M—

Yearly (6y)

20252024202320222021
Revenue$0.5M$0.0M$10.0M$0.0M—
Op margin-7651.4%—-271.4%——
Net income-$41.9M-$43.3M-$29.5M-$42.2M—
Gross margin73.4%—74.3%——
Gross profit$0.4M$0.0M$7.4M$1.1M—
Operating income-$38.3M-$45.7M-$27.1M-$52.7M—
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

MREO · daily+18.6% over 13 sessions
Close EMA21 EMA50 EMA200
0.280.320.360.390.432026-092026-092026-092026-092026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$15M-$11M-$7M-$3M$1M-1951%-939%74%2025-Q22025-Q32025-Q42026-Q12026-Q2